Have a feature idea you'd love to see implemented?
Let us know!
DRIO DarioHealth Corp
Price (delayed)
$0.95
Market cap
$28.53M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.18
Enterprise value
$36.22M
DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software
Highlights
DRIO's EPS is up by 46% year-on-year and by 30% since the previous quarter
The company's net income rose by 12% YoY and by 6% QoQ
DarioHealth's gross profit has decreased by 39% YoY but it has increased by 13% from the previous quarter
The gross margin has decreased by 16% YoY but it has increased by 12% QoQ
The quick ratio has shrunk by 74% YoY and by 27% QoQ
The revenue has declined by 28% year-on-year
Key stats
What are the main financial stats of DRIO
Market
Valuations
Earnings
Shares outstanding
30.03M
Market cap
$28.53M
Enterprise value
$36.22M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.42
Price to sales (P/S)
1.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.89
Revenue
$19.15M
EBIT
-$52.73M
EBITDA
-$47.01M
Free cash flow
-$40.91M
Per share
Balance sheet
Liquidity
EPS
-$1.18
Free cash flow per share
-$1.03
Book value per share
$2.27
Revenue per share
$0.48
TBVPS
$1.06
Total assets
$122.13M
Total liabilities
$54.08M
Debt
$30.63M
Equity
$68.06M
Working capital
$21.92M
Debt to equity
0.45
Current ratio
2.26
Quick ratio
1.96
Net debt/EBITDA
-0.16
Margins
Efficiency
Dividend
EBITDA margin
-245.5%
Gross margin
31%
Net margin
-265.3%
Operating margin
-333.2%
Return on assets
-40.3%
Return on equity
-68.3%
Return on invested capital
-159%
Return on capital employed
-50.4%
Return on sales
-275.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
DRIO stock price
How has the DarioHealth stock price performed over time
Intraday
-0.14%
1 week
-6.58%
1 month
2.15%
1 year
-58.15%
YTD
-44.77%
QTD
-15.18%
Financial performance
How have DarioHealth's revenue and profit performed over time
Revenue
$19.15M
Gross profit
$5.93M
Operating income
-$63.81M
Net income
-$50.8M
Gross margin
31%
Net margin
-265.3%
DRIO's operating margin has dropped by 77% year-on-year and by 2.9% since the previous quarter
DarioHealth's gross profit has decreased by 39% YoY but it has increased by 13% from the previous quarter
The revenue has declined by 28% year-on-year
DarioHealth's operating income has decreased by 28% YoY and by 3.5% from the previous quarter
Growth
What is DarioHealth's growth rate over time
Valuation
What is DarioHealth stock price valuation
P/E
N/A
P/B
0.42
P/S
1.98
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.89
DRIO's EPS is up by 46% year-on-year and by 30% since the previous quarter
The P/B is 75% lower than the 5-year quarterly average of 1.7 and 48% lower than the last 4 quarters average of 0.8
DRIO's equity is down by 13% year-on-year and by 13% since the previous quarter
DRIO's P/S is 75% below its 5-year quarterly average of 8.0 and 32% below its last 4 quarters average of 2.9
The revenue has declined by 28% year-on-year
Efficiency
How efficient is DarioHealth business performance
DRIO's ROS is down by 27% year-on-year but it is up by 6% since the previous quarter
DRIO's ROA is up by 23% QoQ and by 21% YoY
DarioHealth's return on equity has increased by 19% QoQ and by 9% YoY
The ROIC has grown by 16% YoY and by 2% from the previous quarter
Dividends
What is DRIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for DRIO.
Financial health
How did DarioHealth financials performed over time
The total assets is 126% greater than the total liabilities
The quick ratio has shrunk by 74% YoY and by 27% QoQ
DarioHealth's current ratio has plunged by 72% YoY and by 23% from the previous quarter
The debt is 55% less than the equity
The company's debt to equity rose by 18% YoY and by 15% QoQ
DRIO's equity is down by 13% year-on-year and by 13% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.